-
Je něco špatně v tomto záznamu ?
Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels
JE Mickle, MI Milewski, M Jr Macek, GR Cutting
Jazyk angličtina Země Spojené státy americké
Typ dokumentu práce podpořená grantem, Research Support, U.S. Gov't, P.H.S.
Grantová podpora
IZ2899
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
Cell Press Free Archives
od 1997-01-01 do Před 6 měsíci
Free Medical Journals
od 1949 do Před 6 měsíci
PubMed Central
od 1949 do Před 6 měsíci
Europe PubMed Central
od 1949 do Před 6 měsíci
PubMed
10762539
Knihovny.cz E-zdroje
- MeSH
- AMP cyklický metabolismus MeSH
- buněčné linie MeSH
- chloridové kanály antagonisté a inhibitory metabolismus MeSH
- chloridy metabolismus MeSH
- cystická fibróza * genetika patofyziologie MeSH
- ductus deferens * abnormality metabolismus MeSH
- elektrická vodivost MeSH
- fenotyp MeSH
- glibenklamid farmakologie MeSH
- glykosylace MeSH
- kyselina 4,4'-diisothiokyanostilben-2,2'-disulfonová farmakologie MeSH
- lidé MeSH
- missense mutace genetika MeSH
- molekulová hmotnost MeSH
- mutace * genetika MeSH
- protein CFTR antagonisté a inhibitory genetika chemie metabolismus MeSH
- rekombinantní proteiny antagonisté a inhibitory genetika chemie metabolismus MeSH
- substituce aminokyselin genetika MeSH
- vazebná místa MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- práce podpořená grantem MeSH
- Research Support, U.S. Gov't, P.H.S. MeSH
The protein defective in cystic fibrosis (CF), the CF transmembrane-conductance regulator (CFTR), functions as an epithelial chloride channel and as a regulator of separate ion channels. Although the consequences that disease-causing mutations have on the chloride-channel function have been studied extensively, little is known about the effects that mutations have on the regulatory function. To address this issue, we transiently expressed CFTR-bearing mutations associated with CF or its milder phenotype, congenital bilateral absence of the vas deferens, and determined whether mutant CFTR could regulate outwardly rectifying chloride channels (ORCCs). CFTR bearing a CF-associated mutation in the first nucleotide-binding domain (NBD1), DeltaF508, functioned as a chloride channel but did not regulate ORCCs. However, CFTR bearing disease-associated mutations in other domains retained both functions, regardless of the associated phenotype. Thus, a relationship between loss of CFTR regulatory function and disease severity is evident for NBD1, a region of CFTR that appears important for regulation of separate channels.
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13016538
- 003
- CZ-PrNML
- 005
- 20130502102513.0
- 007
- ta
- 008
- 130426s2000 xxuad f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)10762539
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Mickle, John E. $u Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- 245 10
- $a Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels / $c JE Mickle, MI Milewski, M Jr Macek, GR Cutting
- 504 __
- $a Literatura
- 520 9_
- $a The protein defective in cystic fibrosis (CF), the CF transmembrane-conductance regulator (CFTR), functions as an epithelial chloride channel and as a regulator of separate ion channels. Although the consequences that disease-causing mutations have on the chloride-channel function have been studied extensively, little is known about the effects that mutations have on the regulatory function. To address this issue, we transiently expressed CFTR-bearing mutations associated with CF or its milder phenotype, congenital bilateral absence of the vas deferens, and determined whether mutant CFTR could regulate outwardly rectifying chloride channels (ORCCs). CFTR bearing a CF-associated mutation in the first nucleotide-binding domain (NBD1), DeltaF508, functioned as a chloride channel but did not regulate ORCCs. However, CFTR bearing disease-associated mutations in other domains retained both functions, regardless of the associated phenotype. Thus, a relationship between loss of CFTR regulatory function and disease severity is evident for NBD1, a region of CFTR that appears important for regulation of separate channels.
- 536 __
- $c Grant Number: DK44003 (United States NIDDK NIH HHS)
- 536 __
- $c Grant Number: DK48977 (United States NIDDK NIH HHS)
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a kyselina 4,4'-diisothiokyanostilben-2,2'-disulfonová $x farmakologie $7 D017878
- 650 02
- $a substituce aminokyselin $x genetika $7 D019943
- 650 02
- $a vazebná místa $7 D001665
- 650 02
- $a buněčné linie $7 D002460
- 650 02
- $a chloridové kanály $x antagonisté a inhibitory $x metabolismus $7 D018118
- 650 02
- $a chloridy $x metabolismus $7 D002712
- 650 02
- $a AMP cyklický $x metabolismus $7 D000242
- 650 12
- $a cystická fibróza $x genetika $x patofyziologie $7 D003550
- 650 02
- $a protein CFTR $x antagonisté a inhibitory $x genetika $x chemie $x metabolismus $7 D019005
- 650 02
- $a elektrická vodivost $7 D004553
- 650 02
- $a glibenklamid $x farmakologie $7 D005905
- 650 02
- $a glykosylace $7 D006031
- 650 02
- $a lidé $7 D006801
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a molekulová hmotnost $7 D008970
- 650 12
- $a mutace $x genetika $7 D009154
- 650 02
- $a missense mutace $x genetika $7 D020125
- 650 02
- $a fenotyp $7 D010641
- 650 02
- $a rekombinantní proteiny $x antagonisté a inhibitory $7 D011994
- 650 02
- $a rekombinantní proteiny $x genetika $x chemie $x metabolismus $7 D011994
- 650 12
- $a ductus deferens $x abnormality $x metabolismus $7 D014649
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a Research Support, U.S. Gov't, P.H.S. $7 D013487
- 700 1_
- $a Milewski, Michał I.
- 700 1_
- $a Macek, Milan, $d 1961- $7 mzk2006348713 $u Institute of Biology and Medical Genetics, Department of Molecular Genetics, Cystic Fibrosis Center, University Hospital Motol and Second School of Medicine of Charles University, Prague
- 700 1_
- $a Cutting, Garry R.
- 773 0_
- $t American Journal of Human Genetics $x 0002-9297 $g Roč. 66, č. 5 (2000), s. 1485-1495 $p Am J Hum Genet $w MED00000254
- 773 0_
- $p Am J Hum Genet $g 66(5):1485-95, 2000 May $x 0002-9297
- 910 __
- $a ABA008 $b A 3419 $y 3 $z 0
- 990 __
- $a 20130426130656 $b ABA008
- 991 __
- $a 20130502102809 $b ABA008
- 999 __
- $a ok $b bmc $g 979811 $s 814863
- BAS __
- $a 3
- BMC __
- $a 2000 $b 66 $c 5 $d 1485-1495 $i 0002-9297 $m American journal of human genetics $x MED00000254 $n Am J Hum Genet
- GRA __
- $a IZ2899 $p MZ0
- LZP __
- $a 2013-04/dpbo